2005
DOI: 10.1081/copd-200057580
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Quantifiable Symptom Assessment Tool for Patients with Chronic Bronchitis: The Chronic Bronchitis Symptoms Assessment Scale

Abstract: Clinical trials that rely solely on physiologic outcomes may underestimate effects of interventions on patients' symptoms and well-being. We sought to develop and validate an instrument to reliably assess symptom severity and frequency in therapeutic trials for patients with chronic bronchitis. We performed a series of psychometric studies that determined instrument content and assessed validity and reliability. The final version of the Chronic Bronchitis Symptoms Assessment Scale (CBSAS) comprised 15 scored i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2008
2008
2009
2009

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…These scales could conceivably be applied to CF patients; however, these patient populations differ quite substantially in age, symptom profile, and natural history. They include the Breathlessness, Cough, and Sputum Scale (BCSS), the Clinical COPD Questionnaire (CCQ) and the Chronic Bronchitis Symptoms Assessment Scale (CBSAS) for chronic obstructive pulmonary disease [52][53][54][55]. It is not known how these instruments developed for either asthma or COPD will perform in the CF population.…”
Section: Discussionmentioning
confidence: 99%
“…These scales could conceivably be applied to CF patients; however, these patient populations differ quite substantially in age, symptom profile, and natural history. They include the Breathlessness, Cough, and Sputum Scale (BCSS), the Clinical COPD Questionnaire (CCQ) and the Chronic Bronchitis Symptoms Assessment Scale (CBSAS) for chronic obstructive pulmonary disease [52][53][54][55]. It is not known how these instruments developed for either asthma or COPD will perform in the CF population.…”
Section: Discussionmentioning
confidence: 99%
“…Initially developed in psychometrics to assess the severity of behavioral troubles or disturbances [1,2], ORS became essential in health research tools to measure clinical outcomes such as symptoms [3,4], pathologist findings [5,6], disease severity [7,8], treatment response [9,10], and health-related quality of life [11,12]. The use of ORS allows clinicians to classify patients, in an objective and homogeneous way, into different patients' categories for which standardized treatment and management could be defined.…”
Section: Introductionmentioning
confidence: 99%